[Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
D000328:Adult; D000368:Aged; D000405:Akinetic Mutism / Q000150:complications; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D010301:Parkinson Disease, Postencephalitic / Q000175:diagnosis / Q000188:drug therapy; D011581:Psychological Tests; D013997:Time Factors
D004295:Dihydroxyphenylalanine
Quantitative Testmethoden zur Objektivierung des Effekts einer L-Dopa Langzeittherapie beim Parkinson-Syndrom.